Results 291 to 300 of about 1,044,818 (308)

Pulsed monoclonal antibody treatment and autoimmune thyroid disease in multiple sclerosis

Lancet, The, 1999
Anthony Weetman, Geoff Hale, Herman Waldmann   +2 more
exaly  

Secukinumab, a human anti-interleukin-17A monoclonal antibody, in patients with psoriatic arthritis (FUTURE 2): a randomised, double-blind, placebo-controlled, phase 3 trial

Lancet, The, 2015
Iain B Mcinnes, Philip J Mease, Bruce W Kirkham   +2 more
exaly  

Prevalence and risk of progression of light-chain monoclonal gammopathy of undetermined significance: a retrospective population-based cohort study

Lancet, The, 2010
Angela Dispenzieri, Robert A Kyle, Dirk Larson   +2 more
exaly  

New developments in monoclonal antibodies for cancer detection and therapy

Ca-A Cancer Journal for Clinicians, 1994
exaly  

Double-blind randomised controlled trial of monoclonal antibody to human tumour necrosis factor in treatment of septic shock

Lancet, The, 1998
Robert Baughman
exaly  

Development trends for monoclonal antibody cancer therapeutics

Nature Reviews Drug Discovery, 2007
exaly  

Monoclonal antibodies

Reactions Weekly, 2022
openaire   +1 more source

Human monoclonal antibody as prophylaxis for SARS coronavirus infection in ferrets

Lancet, The, 2004
Jan Ter Meulen, Bart L Haagmans, Thijs Kuiken   +2 more
exaly  

Benralizumab, an anti-interleukin-5 receptor α monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): a randomised, double-blind, placebo-controlled phase 3 trial

Lancet, The, 2016
J Mark Fitzgerald, Eugene R Bleecker, Parameswaran Nair   +2 more
exaly  

Development trends for human monoclonal antibody therapeutics

Nature Reviews Drug Discovery, 2010
exaly